NO965608L - Vitronectin receptor antagonists - Google Patents

Vitronectin receptor antagonists

Info

Publication number
NO965608L
NO965608L NO965608A NO965608A NO965608L NO 965608 L NO965608 L NO 965608L NO 965608 A NO965608 A NO 965608A NO 965608 A NO965608 A NO 965608A NO 965608 L NO965608 L NO 965608L
Authority
NO
Norway
Prior art keywords
receptor antagonists
vitronectin receptor
vitronectin
antagonists
Prior art date
Application number
NO965608A
Other languages
Norwegian (no)
Other versions
NO965608D0 (en
Inventor
Fadia Ali
William Edward Bondinell
William Francis Huffmann
M Amparo Lago
Richard Mcculloch Keenan
Chet Kwon
William Henry Miller
Thomas Nguyen
Dennis T Takata
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US26769594A priority Critical
Priority to US42893395A priority
Priority to PCT/US1995/008306 priority patent/WO1996000730A1/en
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO965608D0 publication Critical patent/NO965608D0/en
Publication of NO965608L publication Critical patent/NO965608L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1,4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1,4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
NO965608A 1994-06-29 1996-12-27 Vitronectin receptor antagonists NO965608L (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US26769594A true 1994-06-29 1994-06-29
US42893395A true 1995-04-25 1995-04-25
PCT/US1995/008306 WO1996000730A1 (en) 1994-06-29 1995-06-29 Vitronectin receptor antagonists

Publications (2)

Publication Number Publication Date
NO965608D0 NO965608D0 (en) 1996-12-27
NO965608L true NO965608L (en) 1997-02-27

Family

ID=26952569

Family Applications (1)

Application Number Title Priority Date Filing Date
NO965608A NO965608L (en) 1994-06-29 1996-12-27 Vitronectin receptor antagonists

Country Status (13)

Country Link
EP (1) EP0767792A4 (en)
JP (1) JPH10504808A (en)
CN (1) CN1156995A (en)
AU (1) AU702661B2 (en)
BR (1) BR9508178A (en)
CA (1) CA2193966A1 (en)
CZ (1) CZ382496A3 (en)
HU (1) HUT76344A (en)
MX (1) MX9700041A (en)
NO (1) NO965608L (en)
NZ (3) NZ290008A (en)
PL (1) PL318199A1 (en)
WO (1) WO1996000730A1 (en)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO118289B1 (en) 1995-08-30 2003-04-30 Gd Searle & Co Chicago Phenyl carbonyl urea derivatives and pharmaceutical composition
US6100423A (en) * 1995-08-30 2000-08-08 G. D. Searle & Co. Amino benzenepropanoic acid compounds and derivatives thereof
US6011029A (en) * 1996-02-26 2000-01-04 Bristol-Myers Squibb Company Inhibitors of farnesyl protein transferase
PT796855E (en) 1996-03-20 2002-07-31 Hoechst Ag Inhibition of reabsorcao in bones and antagonists of vitronectin
DE19629817A1 (en) * 1996-07-24 1998-01-29 Hoechst Ag New imino derivatives as inhibitors of bone resorption and vitronectin receptor antagonists
DE19629816A1 (en) * 1996-07-24 1998-01-29 Hoechst Ag New cycloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists
DZ2320A1 (en) * 1996-10-02 2002-12-28 Smithkline Beecham Corp Antagonists of vitronectin receptors.
WO1998015278A1 (en) * 1996-10-07 1998-04-16 Smithkline Beecham Corporation Method for stimulating bone formation
DE19653646A1 (en) * 1996-12-20 1998-06-25 Hoechst Ag Substituted purine derivatives, processes for their preparation, to compositions comprising them and their use
US6482821B2 (en) 1996-12-20 2002-11-19 Hoechst Aktiengellschaft Vitronectin receptor antagonists, their preparation and their use
US6218387B1 (en) 1996-12-20 2001-04-17 Hoechst Aktiengesellschaft Vitronectin receptor anatagonists, their preparation and their use
DE19653645A1 (en) * 1996-12-20 1998-06-25 Hoechst Ag Vitronectin - receptor antagonists, their preparation and their use
DE19653647A1 (en) * 1996-12-20 1998-06-25 Hoechst Ag Vitronectin - receptor antagonists, their preparation and their use
US6214834B1 (en) 1997-03-28 2001-04-10 Dupont Pharmaceuticals Company Integrin inhibitor prodrugs
JP2001511452A (en) * 1997-08-04 2001-08-14 スミスクライン・ビーチャム・コーポレイション Integrin receptor antagonists
US6313119B1 (en) 1998-01-23 2001-11-06 Adventis Pharma Deutschland Gmbh Sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion
US6548663B1 (en) 1998-03-31 2003-04-15 Bristol-Myers Squibb Pharma Company Benzodiazepine vitronectin receptor antagonist pharmaceuticals
JP2003504301A (en) 1998-04-01 2003-02-04 ブリストル−マイヤーズ スクイブ ファーマ カンパニー Integrin antagonists
US6228985B1 (en) 1998-05-21 2001-05-08 Schering Corporation Derivatives of aminobenzoic and aminobiphenylcarboxylic acids useful as anti-cancer agents
CZ2001447A3 (en) * 1998-08-07 2001-08-15 Smithkline Beecham Corporation Vitronectin receptor antagonist
DE19842415A1 (en) 1998-09-16 2000-03-23 Merck Patent Gmbh Pharmaceutical preparation for treating e.g. tumors, thrombosis or inflammation, contains cyclic pentapeptide integrin inhibitor and chemotherapeutic agent and/or angiogenesis inhibitor
US6160099A (en) * 1998-11-24 2000-12-12 Jonak; Zdenka Ludmila Anti-human αv β3 and αv β5 antibodies
US6204282B1 (en) 1998-11-30 2001-03-20 Schering Corporation Benzimidazole compounds that are vitronectin receptor antagonists
CN1161340C (en) * 1998-11-30 2004-08-11 先灵公司 Benzimidazole compounds that are vitronectin receptor antagoninsts
US6339083B1 (en) 1998-12-14 2002-01-15 Bayer Aktiengesellschaft Multiheterocyclic pharmAceuticals
US6569402B1 (en) 1998-12-18 2003-05-27 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
US6558649B1 (en) 1998-12-18 2003-05-06 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
EP1150965A4 (en) 1999-02-03 2002-05-15 Merck & Co Inc Benzazepine derivatives as alpha-v integrin receptor antagonists
EP1028114A1 (en) 1999-02-13 2000-08-16 Aventis Pharma Deutschland GmbH Novel guanidine derivatives as inhibitors of cell adhesion
US6380210B1 (en) 1999-04-02 2002-04-30 Neurogen Corporation Heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors
US6271241B1 (en) 1999-04-02 2001-08-07 Neurogen Corporation Cycloalkyl and aryl fused aminoalkyl-imidazole derivatives: modulators and GLP-1 receptors
US6627624B1 (en) 1999-04-02 2003-09-30 Neurogen Corporation Aryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors
US6358949B1 (en) 1999-04-02 2002-03-19 Neurogen Corporation Aryl and hetroaryl fused aminoalkyl-imidazole derivatives: selective modulators of bradykinin B2 receptors
AU4055300A (en) * 1999-04-02 2000-10-23 Neurogen Corporation Aryl and heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of Bradykinin B2 receptors
US6281237B1 (en) 1999-04-02 2001-08-28 Neurogen Corporation N-phenyl benzimidazolecarboxamide and N-phenyl indolecarboxamide derivatives
WO2000059905A1 (en) * 1999-04-02 2000-10-12 Neurogen Corporation ARYL AND HETEROARYL FUSED AMINOALKYL-IMIDAZOLE DERIVATIVES: SELECTIVE MODULATORS OF GABAa RECEPTORS
CZ20013593A3 (en) 1999-04-06 2002-03-13 Sankyo Company, Limited Alpha-substituted derivatives of carboxylic acids
CO5180550A1 (en) 1999-04-19 2002-07-30 Smithkline Beecham Corp Inhibitors fab i
AR024158A1 (en) 1999-06-01 2002-09-04 Smithkline Beecham Corp antibacterials
US6762201B1 (en) 1999-10-08 2004-07-13 Affinium Pharmaceuticals, Inc. Fab I inhibitors
US6730684B1 (en) 1999-10-08 2004-05-04 Affinium Pharmaceuticals, Inc. Fab I inhibitors
HU230030B1 (en) 1999-10-08 2015-05-28 Debiopharm Int Sa Fab i inhibitors
TWI283577B (en) * 1999-10-11 2007-07-11 Sod Conseils Rech Applic Pharmaceutical composition of imidazole derivatives acting as modulators of sodium channels and the use thereof
AU2958001A (en) 2000-01-18 2001-08-14 Nuerogen Corp Substituted imidazoles as selective modulators of bradykinin B<sub>2</sub> receptors
FR2806082B1 (en) * 2000-03-07 2002-05-17 Adir New bicyclic compounds receptor antagonists of vitronectin, their process for the preparation and pharmaceutical compositions containing them
US7037666B2 (en) 2000-05-26 2006-05-02 Smithkline Beecham Corporation Methods for identifying modulators of the interaction between lap (latency associated peptide) and intergrin αvβ3 and medical use thereof
DE60128102T2 (en) 2000-08-01 2008-01-03 Societe De Conseils De Recherches Et D`Applications Scientifiques (S.C.R.A.S.) imidazole derivatives
US20020072518A1 (en) * 2000-08-29 2002-06-13 Khanna Ish Kumar Bicyclic alphavbeta3 antagonists
FR2822463B1 (en) 2001-03-21 2004-07-30 Lipha Bicyclic derivatives of guanidine and their applications in therapeutics
CA2444597A1 (en) 2001-04-06 2002-10-06 Affinium Pharmaceuticals, Inc. Fab i inhibitors
ES2366775T3 (en) 2001-04-24 2011-10-25 Merck Patent Gmbh USING polytherapy antiangiogenic agents and TNF (alpha).
US7030150B2 (en) 2001-05-11 2006-04-18 Trimeris, Inc. Benzimidazole compounds and antiviral uses thereof
FR2829765A1 (en) * 2001-09-14 2003-03-21 Lipha Use of new and known benzimidazolyl alkoxyaryl alkanoic acid derivatives for treating pathologies associated with insulin resistance or hyperglycemia
KR20040058229A (en) 2001-10-22 2004-07-03 더 스크립스 리서치 인스티튜트 Antibody targeting compounds
FR2847254B1 (en) 2002-11-19 2005-01-28 Aventis Pharma Sa New derivatives antagonists of vitronectin receptor, method of preparing them, their use as medicines and pharmaceutical compositions closing the
PE08042004A1 (en) * 2002-12-19 2004-12-31 Boehringer Ingelheim Pharma Carboxamides DERIVATIVES AS FACTOR Xa INHIBITORS
FR2870541B1 (en) * 2004-05-18 2006-07-14 Proskelia Sas Pyrimidine derivatives of the receiver antigonistes vitronectin
MY147997A (en) 2004-06-07 2013-02-28 Merck Sharp & Dohme N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
EA201200560A1 (en) 2006-01-18 2012-09-28 Мерк Патент Гмбх Specific therapy using integrine ligands for cancer treatment
CA2675813A1 (en) 2007-01-18 2008-07-24 Merck Patent Gesellschaft Mit Beschraenkter Haftung Specific therapy and medicament using integrin ligands for treating cancer
JP5468899B2 (en) 2006-07-20 2014-04-09 アフィニウム ファーマシューティカルズ, インク.Affinium Pharmaceuticals, Inc. Acrylamide derivatives as inhibitors Fabi
WO2008098374A1 (en) 2007-02-16 2008-08-21 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab i inhibitors
CN101861319B (en) 2007-11-16 2013-12-11 宇部兴产株式会社 Benzazepinone compound
US8518927B2 (en) 2009-02-10 2013-08-27 The Scripps Research Institute Chemically programmed vaccination
JP5572996B2 (en) * 2009-05-15 2014-08-20 宇部興産株式会社 Pharmaceutical comprising the benzazepinone compound as an active ingredient
EP2445534A2 (en) 2009-05-25 2012-05-02 Merck Patent GmbH Continuous administration of cilengitide in cancer treatments
RS54761B1 (en) 2010-06-24 2016-10-31 Gilead Sciences Pyrazolo[1,5-a]pyrimidines and -triazines as antiviral agents
JP6122868B2 (en) 2011-12-22 2017-04-26 ギリアード サイエンシーズ, インコーポレイテッド Pyrazolo as antiviral agents [1,5-a] pyrimidine
NZ701647A (en) 2012-04-17 2016-05-27 Gilead Sciences Inc Compounds and methods for antiviral treatment
NZ702695A (en) 2012-06-19 2015-10-30 Debiopharm Int Sa Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
RU2016146826A3 (en) 2014-05-30 2018-12-29

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR71915B (en) * 1979-11-27 1983-08-16 Pfizer
US4556660A (en) * 1982-07-12 1985-12-03 Janssen Pharmaceutica N.V. N-(Bicyclic heterocyclyl)-4-piperidinamines
GB8316645D0 (en) * 1983-06-18 1983-07-20 Wyeth John & Brother Ltd Heterocyclic compounds
FR2643903A1 (en) * 1989-03-03 1990-09-07 Union Pharma Scient Appl Novel benzimidazole derivatives, processes for preparing same, synthesis intermediates, pharmaceutical compositions containing same, in particular for the treatment of cardiovascular diseases, and duodenial ulcers
US5185351A (en) * 1989-06-14 1993-02-09 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
RU1836357C (en) * 1990-07-23 1993-08-23 Др.Карл Томэ ГмбХ Benzimidazole derivatives, their isomers, mixtures of isomers, hydrates or their physiologically bearable salts possessing properties antagonistic to angiotenzine
DE69232854T2 (en) * 1991-06-28 2003-09-04 Smithkline Beecham Corp bicyclic fibrinogen
US5250679A (en) * 1991-10-18 1993-10-05 Genentech, Inc. Nonpeptidyl platelet aggregation inhibitors having specificity for the GPIIb III.sub. receptor
CA2152631A1 (en) * 1992-12-21 1994-07-07 William Edward Bondinell Bicyclic fibrinogen antagonists
CA2153777A1 (en) * 1993-01-15 1994-07-21 Siegfried H. Reich Hiv protease inhibitors
US5300668A (en) * 1993-03-10 1994-04-05 Pfizer Inc. Certain esters of 1-(4-X-methylphenyl)cyclopent-3-ene-1-carboxylic acid, wherein X is a trialkylsilyloxy, bromo or hydroxy group, as intermediates

Also Published As

Publication number Publication date
BR9508178A (en) 1997-11-18
NO965608D0 (en) 1996-12-27
NZ329822A (en) 2000-02-28
EP0767792A1 (en) 1997-04-16
PL318199A1 (en) 1997-05-26
JPH10504808A (en) 1998-05-12
CA2193966A1 (en) 1996-01-11
NZ329656A (en) 2000-01-28
AU702661B2 (en) 1999-02-25
CZ382496A3 (en) 1997-12-17
EP0767792A4 (en) 2002-11-20
AU3001095A (en) 1996-01-25
CN1156995A (en) 1997-08-13
NZ290008A (en) 1998-08-26
HUT76344A (en) 1997-08-28
WO1996000730A1 (en) 1996-01-11
HU9603525D0 (en) 1997-02-28
MX9700041A (en) 1997-04-30

Similar Documents

Publication Publication Date Title
NO992417L (en) Toothbrush
NO994050D0 (en) Toothbrush
FI970523A0 (en) (Azetidin-1-ylalkyl) lactams as tachykinin antagonists
NO971438D0 (en) Microparticles
NO975989L (en) CB2 receptor agonist compounds
DK0970213T3 (en) Dödsdomæneholdig receptor
NO955167D0 (en) monoclonal anti-
DE69416869T2 (en) antagonists diazabicyclic neurokinin
NO965450D0 (en) Life-element for concrete stöpeformvegger
NO20022481D0 (en) NPYY5 antagonists
NO20022835D0 (en) Substituted imidazolneuropeptid Y Y5 receptor antagonists
BR9508375A (en) Antagonist heterocyclic tachykinin receptor
NO980958L (en) Computerized Gassl ° ftersystem
EE03445B1 (en) Tachykinin (NK-1) receptor antagonists
NL300405I2 (en) Estrogen agonists / antagonists
DK0604494T3 (en) 5-HT 4 receptor antagonists
DK0612244T3 (en) endothelin receptor antagonists
NO980553L (en) endothelin antagonist
NO309424B1 (en) Pyrimidindion-, pyrimidintrion-, triazindion-, tetrahydrokinazolindionderivater as &lt;alpha&gt; 1-adrenergic receptor antagonists
FI941261A0 (en) Bentsanilidijohdannaiset 5-HT 1D antagonists
NO980414D0 (en) benzimidazole
DE69518841D1 (en) antagonists corticotropin
FI952064A (en) Tachykinin receptor antagonists, which have no peptidyylirakennetta
DE69736812D1 (en) antagonists new integrin receptor
DE69207351D1 (en) Fibrinogen receptor antagoniste